Rachel Smith
LightNews LightNews
banner
rachel-smith.bsky.social
Rachel Smith
@rachel-smith.bsky.social
14 followers 35 following 0 posts
🏴󠁧󠁢󠁳󠁣󠁴󠁿
Posts Replies Media Videos
Reposted by Rachel Smith
jtkidney.bsky.social
Appraise for the interim analysis of the #VISIONARY trial in IgAN at #ERA25
June 6, 2025 at 9:33 AM
Reposted by Rachel Smith
nejm.org
In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk

#ERA25 #MedSky #Nephrology
A graph of the least-squares mean ratio of the change from baseline in the urinary albumin-to-creatinine ratio in the full analysis population.
June 5, 2025 at 9:45 AM